SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0000950123-10-035654
Filing Date
2010-04-16
Accepted
2010-04-16 17:25:23
Documents
15

Document Format Files

Seq Description Document Type Size
1 FORM S-1 w78085sv1.htm S-1 1068516
2 EX-3.1 w78085exv3w1.htm EX-3.1 10086
3 EX-3.2 w78085exv3w2.htm EX-3.2 18010
4 EX-3.3 w78085exv3w3.htm EX-3.3 6694
5 EX-3.4 w78085exv3w4.htm EX-3.4 27410
6 EX-4.1 w78085exv4w1.htm EX-4.1 7726
7 EX-4.2 w78085exv4w2.htm EX-4.2 13000
8 EX-4.3 w78085exv4w3.htm EX-4.3 140946
9 EX-4.4 w78085exv4w4.htm EX-4.4 6356
10 EX-23.1 w78085exv23w1.htm EX-23.1 1208
12 GRAPHIC w78085w7808500.gif GRAPHIC 2814
13 GRAPHIC w78085w7808501.gif GRAPHIC 19476
14 GRAPHIC w78085w7808505.gif GRAPHIC 219330
15 GRAPHIC w78085w7808506.gif GRAPHIC 5545
16 filename16.htm CORRESP 4370
  Complete submission text file 0000950123-10-035654.txt   1647037
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-166146 | Film No.: 10755579
SIC: 2834 Pharmaceutical Preparations